{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:04:48Z","timestamp":1775253888761,"version":"3.50.1"},"update-to":[{"DOI":"10.1002\/14651858.cd010893.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000}}],"reference-count":107,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010893.pub3","type":"journal-article","created":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T04:21:38Z","timestamp":1539922898000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interventions for reducing inflammation in familial Mediterranean fever"],"prefix":"10.1002","volume":"2018","author":[{"given":"Bin","family":"Wu","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Pharmacy; No.37,Guoxue Lane Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Xu","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Pharmacy; No.37,Guoxue Lane Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youping","family":"Li","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Chinese Cochrane Centre, Chinese Evidence-Based Medicine Centre; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi","family":"Yin","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Department of Pharmacy; No.37,Guoxue Lane Chengdu Sichuan China 610041"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,10,19]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD010893.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1078\/094471103322004767","article-title":"Double-blind, placebo-controlled, randomized, pilot clinical trial of ImmunoGuard--a standardized fixed combination of Andrographis paniculata Nees, with Eleutherococcus senticosus Maxim, Schizandra chinensis Bail. and Glycyrrhiza glabra L. extracts in patients with Familial Mediterranean Fever","volume":"10","author":"Amaryan","year":"2003","journal-title":"Phytomedicine"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub3-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.niox.2003.08.005","article-title":"Plasma nitric oxide level in familial Mediterranean fever and its modulations by Immuno-Guard","volume":"9","author":"Panossian","year":"2003","journal-title":"Nitric Oxide: Biology and Chemistry"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub3-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/art.39995","article-title":"Anakinra for colchicine-resistant familial Mediterranean fever: a randomized, double-blind, placebo-controlled trial","volume":"69","author":"Ben-Zvi","year":"2017","journal-title":"Arthritis & Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub3-BIB0004|cit4","first-page":"271","article-title":"Colchicine failure in familial Mediterranean fever and potential alternatives: embarking on the anakinra trial","volume":"16","author":"Ben-Zvi","year":"2014","journal-title":"Israel Medical Association Journal"},{"issue":"18","key":"10.1002\/14651858.CD010893.pub3-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1056\/NEJM197410312911804","article-title":"Colchicine therapy for familial Mediterranean fever. A double blind trial","volume":"291","author":"Dinarello","year":"1974","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0006|cit6","first-page":"186","article-title":"Colchicine therapy of familial Mediterranean fever","volume":"87","author":"Wolff","year":"1974","journal-title":"Transactions of the Association of American Physicians"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub3-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"792","DOI":"10.7326\/0003-4819-81-6-792","article-title":"Prophylactic colchicine therapy in familial Mediterranean fever. A controlled, double-blind study","volume":"81","author":"Goldstein","year":"1974","journal-title":"Annals of Internal Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub3-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.7326\/0003-4819-157-8-201210160-00003","article-title":"Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: a randomized trial","volume":"157","author":"Hashkes","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010893.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"O38","DOI":"10.1186\/1546-0096-9-S1-O38","article-title":"Rilonacept (interleukin-1 trap) for treatment of colchicine resistant familial Mediterranean fever: a randomized, multicenter double-blinded, alternating treatment phase II trial","volume":"9","author":"Hashkes","year":"2011","journal-title":"Pediatric Rheumatology"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0010|cit10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/854842","article-title":"The effect of rilonacept versus placebo on health-related quality of life in patients with poorly controlled familial Mediterranean fever","volume":"854842","author":"Hashkes","year":"2014","journal-title":"BioMed Research International"},{"issue":"7","key":"10.1002\/14651858.CD010893.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1177\/000992280404300703","article-title":"Once-daily use of colchicine in children with familial Mediterranean fever","volume":"43","author":"Kosan","year":"2004","journal-title":"Clinical Pediatrics"},{"issue":"85","key":"10.1002\/14651858.CD010893.pub3-BIB0012|cit12","first-page":"1","article-title":"Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever--a randomized controlled non-inferiority trial","volume":"18","author":"Polat","year":"2016","journal-title":"Arthritis Research & Therapy"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub3-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-86-2-162","article-title":"Efficacy of intermittent colchicine therapy in familial Mediterranean fever","volume":"86","author":"Wright","year":"1977","journal-title":"Annals of Internal Medicine"},{"issue":"18","key":"10.1002\/14651858.CD010893.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM197410312911803","article-title":"A controlled trial of colchicine in preventing attacks of familial Mediterranean fever","volume":"291","author":"Zemer","year":"1974","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD010893.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1161\/01.CIR.97.21.2183","article-title":"Colchicine treatment for recurrent pericarditis. A decade of experience","volume":"97","author":"Adler","year":"1998","journal-title":"Circulation"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1007\/s00296-010-1474-6","article-title":"Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever","volume":"32","author":"Alpay","year":"2012","journal-title":"Rheumatology International"},{"issue":"8022","key":"10.1002\/14651858.CD010893.pub3-BIB0017|cit17","first-page":"1140","article-title":"Colchicine in familial Mediterranean fever","volume":"1","author":"Anonymous","year":"1977","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0018|cit18","first-page":"4","article-title":"Colchicine for familial Mediterranean fever","volume":"13","author":"Anonymous","year":"1983","journal-title":"FDA Drug Bulletin"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s00431-008-0875-y","article-title":"Sulphasalazine treatment in protracted familial Mediterranean fever arthritis","volume":"168","author":"Bakkaloglu","year":"2009","journal-title":"European Journal of Pediatrics"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"825","DOI":"10.7326\/0003-4819-146-11-200706050-00023","article-title":"Treatment of familial Mediterranean fever with anakinra","volume":"146","author":"Belkhir","year":"2007","journal-title":"Annals of Internal Medicine"},{"issue":"4 Suppl 50","key":"10.1002\/14651858.CD010893.pub3-BIB0021|cit21","first-page":"S49","article-title":"Non-response to colchicine in FMF-definition, causes and suggested solutions","volume":"26","author":"Ben-Chetrit","year":"2008","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1002\/art.38777","article-title":"Canakinumab for the treatment of children with colchicine-resistant familial Mediterranean fever: a 6-month open-label, single-arm pilot study","volume":"66","author":"Brik","year":"2014","journal-title":"Arthritis & Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s002280050244","article-title":"Chronic colchicine treatment does not impair glucose tolerance in familial Mediterranean fever patients","volume":"52","author":"Burstein","year":"1997","journal-title":"European Journal of Clinical Pharmacology"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00431-007-0547-3","article-title":"The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever","volume":"167","author":"Calligaris","year":"2008","journal-title":"European Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00296-015-3408-9","article-title":"Efficacy and safety of treatments in familial Mediterranean fever: a systematic review","volume":"36","author":"Demirkaya","year":"2016","journal-title":"Rheumatology International"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780190315","article-title":"Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever","volume":"19","author":"Dinarello","year":"1976","journal-title":"Arthritis & Rheumatism"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1365-2362.2007.01868.x","article-title":"Anakinra in two adolescent female patients suffering from colchicine-resistant familial Mediterranean fever: effective but risky","volume":"37","author":"Gattringer","year":"2007","journal-title":"European Journal of Clinical Investigation"},{"issue":"243","key":"10.1002\/14651858.CD010893.pub3-BIB0028|cit28","first-page":"1","article-title":"Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever","volume":"17","author":"G\u00fcl","year":"2015","journal-title":"Arthritis Research & Therapy"},{"issue":"Suppl 11","key":"10.1002\/14651858.CD010893.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1002\/art.38492","article-title":"Long-term efficacy of canakinumab in childhood colchicine resistant familial Mediterranean Fever","volume":"66","author":"Hashkes","year":"2014","journal-title":"Arthritis & Rheumatism"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/14712598.2016.1233963","article-title":"Canakinumab investigated for treating familial Mediterranean fever","volume":"16","author":"Haviv","year":"2016","journal-title":"Expert Opinion on Biological Therapy"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1002\/art.23687","article-title":"Efficacy and safety of rilonacept (interleukin-1 Trap) in patients with cryopyrin-associated periodic syndromes: results from two sequential placebo-controlled studies","volume":"58","author":"Hoffman","year":"2008","journal-title":"Arthritis & Rheumatism"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1136\/ard.2007.071498","article-title":"Effective treatment of a colchicine-resistant familial Mediterranean fever patient with anakinra","volume":"66","author":"Kuijk","year":"2007","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub3-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1053\/S0049-0172(03)00137-9","article-title":"Colchicine non-responsiveness in familial Mediterranean fever: clinical, genetic, pharmacokinetic, and socioeconomic characterization","volume":"33","author":"Lidar","year":"2004","journal-title":"Seminars in Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.rhu.0000255772.25658.7c","article-title":"Familial Mediterranean fever successfully treated with etanercept","volume":"13","author":"Mor","year":"2007","journal-title":"Journal of Clinical Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub3-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ndt\/gfn646","article-title":"Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation","volume":"24","author":"Moser","year":"2009","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejogrb.2008.07.025","article-title":"Familial Mediterranean fever during pregnancy: an independent risk factor for preterm delivery","volume":"141","author":"Ofir","year":"2008","journal-title":"European Journal of Obstetrics, Gynaecology and Reproductive Biology"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/1744666X.2017.1313116","article-title":"Canakinumab for the treatment of familial Mediterranean fever","volume":"13","author":"Ozdogan","year":"2017","journal-title":"Expert Review of Clinical Immunology"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub3-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jbspin.2008.04.001","article-title":"Anakinra: new therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine","volume":"75","author":"Roldan","year":"2008","journal-title":"Joint Bone Spine"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub3-BIB0039|cit39","first-page":"435","article-title":"Etanercept in the treatment of arthritis in a patient with familial Mediterranean fever","volume":"24","author":"Sakallioglu","year":"2006","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD010893.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1093\/ndt\/15.7.1098","article-title":"Colchicine in the treatment of renal amyloidosis secondary to familial Mediterranean fever","volume":"15","author":"Sarkissian","year":"2000","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"4 Suppl 26","key":"10.1002\/14651858.CD010893.pub3-BIB0041|cit41","first-page":"S43","article-title":"Successful treatment of familial Mediterranean fever attacks with thalidomide in a colchicine resistant patient","volume":"20","author":"Seyahi","year":"2002","journal-title":"clinical and Experimental Rheumatology"},{"issue":"5 Suppl 42","key":"10.1002\/14651858.CD010893.pub3-BIB0042|cit42","first-page":"S99","article-title":"Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents","volume":"24","author":"Seyahi","year":"2006","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1093\/ndt\/gfr528","article-title":"Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure","volume":"27","author":"Stankovic Stojanovic","year":"2012","journal-title":"Nephrology, Dialysis, Transplantation"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1136\/annrheumdis-2011-201268","article-title":"Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review","volume":"72","author":"Ter Haar","year":"2013","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"4 Suppl 24","key":"10.1002\/14651858.CD010893.pub3-BIB0045|cit45","first-page":"S37","article-title":"The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: A double-blind, placebo-controlled trial","volume":"22","author":"Tunca","year":"2004","journal-title":"Clinical and Experimental Rheumatology"},{"issue":"7","key":"10.1002\/14651858.CD010893.pub3-BIB0046|cit46","first-page":"1362","article-title":"Interferon-alpha as a treatment modality for colchicine-resistant familial Mediterranean fever","volume":"35","author":"Tweezer-Zaks","year":"2008","journal-title":"Journal of Rheumatology"},{"issue":"Supplement 2","key":"10.1002\/14651858.CD010893.pub3-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/annrheumdis-2017-eular.6885","article-title":"The efficacy of different colchicine doses in treatment of familial Mediterranean fever patients","volume":"76","author":"Uguztemur","year":"2017","journal-title":"Annals of Rheumatic Diseases"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/aje\/kwr460","article-title":"Triggers for attacks in familial Mediterranean fever: application of the case-crossover design","volume":"175","author":"Yenokyan","year":"2012","journal-title":"American Journal of Epidemiology"},{"issue":"16","key":"10.1002\/14651858.CD010893.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM198604173141601","article-title":"Colchicine in the prevention and treatment of the amyloidosis of familial Mediterranean fever","volume":"314","author":"Zemer","year":"1986","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub3-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1002\/art.1780340806","article-title":"Long-term colchicine treatment in children with familial Mediterranean fever","volume":"34","author":"Zemer","year":"1991","journal-title":"Arthritis & Rheumatism"},{"issue":"Supplement 1","key":"10.1002\/14651858.CD010893.pub3-BIB0051|cit51","first-page":"no pagination","article-title":"Efficacy and safety of Canakinumab in patients with periodic fever syndromes (colchicine-resistant fmf, hids\/mkd and traps): results from a phase 3, pivotal, umbrella trial","volume":"15","author":"Benedetti","year":"2017","journal-title":"Pediatric Rheumatology"},{"issue":"20","key":"10.1002\/14651858.CD010893.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMoa1706314","article-title":"Canakinumab for the treatment of autoinflammatory recurrent fever syndromes","volume":"378","author":"Benedetti","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"S10","key":"10.1002\/14651858.CD010893.pub3-BIB0053|cit53","first-page":"no pagination","article-title":"Genetic phenotypes impacting efficacy and safety of canakinumab in patients with colchicine-resistant FMF, traps and HIDS\/MKD: results from cluster study","volume":"69","author":"Benedetti","year":"2017","journal-title":"Arthritis & Rheumatology"},{"issue":"S10","key":"10.1002\/14651858.CD010893.pub3-BIB0054|cit54","first-page":"398","article-title":"Improvement of disease activity in patients with colchicine-resistant FMF, HIDS\/MKD and traps assessed by autoinflammatory disease activity index (AIDAI): Results from a randomized phase iii trial","volume":"69","author":"Kone-Paut","year":"2017","journal-title":"Arthritis & Rheumatology"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0055|cit55","unstructured":"Lachmann H Simon A Anton J Gattorno M Kone-Paut I Ozen S Effect of canakinumab on health-related quality of life in patients with periodic fever syndromes Pediatric Rheumatology. Conference: 23rd Paediatric Rheumatology European Society Congress 2017 no pagination"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0056|cit56","unstructured":"NCT03446209 Tocilizumab for the treatment of familial Mediterranean fever clinicaltrials.gov\/ct2\/show\/NCT03446209"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub3-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1093\/ndt\/17.11.1921","article-title":"MEFV gene mutations in familial Mediterranean fever phenotype II patients with renal amyloidosis in childhood: a retrospective clinicopathological and molecular study","volume":"17","author":"Balci","year":"2002","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub3-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10067-002-0682-1","article-title":"Serum sIL-2r, IL-6, IL-10 and\u00a0TNF-alpha\u00a0level\u00a0in\u00a0familial Mediterranean fever\u00a0patients","volume":"22","author":"Baykal","year":"2003","journal-title":"Clinical Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub3-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/kei140","article-title":"Mechanism\u00a0of the\u00a0anti-inflammatory\u00a0effect\u00a0of\u00a0colchicine\u00a0in\u00a0rheumatic diseases: a possible new outlook through microarray analysis","volume":"45","author":"Ben-Chetrit","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1002\/14651858.CD010893.pub3-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/RHU.0b013e31823682f5","article-title":"Effects of anti-tumor necrosis factor agents for familial Mediterranean fever patients with chronic arthritis and\/or sacroiliitis who were resistant to colchicine treatment","volume":"17","author":"Bilgen","year":"2011","journal-title":"Journal of Clinical Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub3-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V95.10.3223","article-title":"The\u00a0gene\u00a0for\u00a0familial\u00a0Mediterranean\u00a0fever,\u00a0MEFV, is\u00a0expressed\u00a0in\u00a0early\u00a0leukocyte\u00a0development\u00a0and is\u00a0regulated\u00a0in response\u00a0to\u00a0inflammatory\u00a0mediators","volume":"95","author":"Centola","year":"2000","journal-title":"Blood"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1568010053622984","article-title":"Pharmacological and clinical basis of treatment of Familial Mediterranean Fever (FMF) with colchicine or analogues: an update","volume":"4","author":"Cerquaglia","year":"2005","journal-title":"Current Drug Targets.\u00a0Inflammation\u00a0and\u00a0Allergy"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub3-BIB0063|cit63","first-page":"467","article-title":"Advances\u00a0in the\u00a0understanding\u00a0of\u00a0familial\u00a0Mediterranean\u00a0fever\u00a0and\u00a0possibilities\u00a0for\u00a0targeted\u00a0therapy","volume":"146","author":"Chae","year":"2009","journal-title":"British\u00a0Journal of\u00a0Haematology"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0064|cit64","first-page":"S3","article-title":"The\u00a0inflammatory\u00a0process\u00a0of\u00a0gout\u00a0and its\u00a0treatment","volume":"8 Suppl 1","author":"Cronstein","year":"2006","journal-title":"Arthritis\u00a0Research and\u00a0Therapy"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0065|cit65","unstructured":"Deeks JJ Higgins JPT Altman DGonbehalfoftheCSMG editor(s) Chapter 9: Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from cochrane-handbook.org"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nm811","article-title":"Cytokine\u00a0traps:\u00a0multi-component,\u00a0high-affinity\u00a0blockers\u00a0of\u00a0cytokine\u00a0action","volume":"9","author":"Economides","year":"2003","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0068|cit68","unstructured":"Thomson Reuters Endnote X6 2012"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0069|cit69","first-page":"25","article-title":"A\u00a0candidate\u00a0gene\u00a0for\u00a0familial Mediterranean fever","volume":"17","author":"French FMF Consortium","year":"1997","journal-title":"Nature Genetics"},{"issue":"25","key":"10.1002\/14651858.CD010893.pub3-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJM197212212872514","article-title":"Colchicine\u00a0for\u00a0familial Mediterranean fever","volume":"287","author":"Goldfinger","year":"1972","journal-title":"The New England Journal of Medicine"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0071|cit71","unstructured":"The GRADE Working Group GRADE Profiler 3.6 for Windows http:\/\/tech.cochrane.org\/revman\/gradepro 2013"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub3-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/eji.201746947","article-title":"Function and mechanism of the pyrin inflammasome","volume":"48","author":"Heilig","year":"2018","journal-title":"European Journal of Immunology"},{"issue":"7414","key":"10.1002\/14651858.CD010893.pub3-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0074|cit74","unstructured":"Higgins JPT Deeks JJ (editors) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0075|cit75","unstructured":"Higgins JPT Altman DG Sterne JAC on behalf of the CSMG and the CBMG editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0076|cit76","unstructured":"Higgins JPT Deeks JJ Altman DG on behalf of the CSMG editor(s) Chapter 16: Special topics in statistics. In: Higgins JPT, Green S editor(s). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub3-BIB0077|cit77","first-page":"721","article-title":"Effects\u00a0of\u00a0colchicine\u00a0on\u00a0inflammatory\u00a0cytokines\u00a0and\u00a0selectins\u00a0in\u00a0familial\u00a0Mediterranean\u00a0fever","volume":"16","author":"Kiraz","year":"1998","journal-title":"Clinical\u00a0and Experimental Rheumatology"},{"issue":"5","key":"10.1002\/14651858.CD010893.pub3-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1136\/ard.62.5.479","article-title":"Familial Mediterranean fever\u00a0associated\u00a0pyrin\u00a0mutations\u00a0in\u00a0Greece","volume":"62","author":"Konstantopoulos","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"2","key":"10.1002\/14651858.CD010893.pub3-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jbspin.2010.09.021","article-title":"Current\u00a0data\u00a0on\u00a0familial Mediterranean fever","volume":"78","author":"Kon\u00e9-Paut","year":"2011","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0080|cit80","first-page":"50","article-title":"Familial Mediterranean fever\u00a0is no\u00a0longer\u00a0a\u00a0rare disease\u00a0in\u00a0Italy","volume":"11","author":"Regina","year":"2003","journal-title":"European\u00a0Journal of\u00a0Human Genetics"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub3-BIB0081|cit81","first-page":"1089","article-title":"The\u00a0prodrome: a\u00a0prominent\u00a0yet\u00a0overlooked\u00a0pre-attack\u00a0manifestation\u00a0of\u00a0familial\u00a0Mediterranean\u00a0fever","volume":"33","author":"Lidar","year":"2006","journal-title":"Journal of Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub3-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1002\/art.1780401023","article-title":"Criteria for the diagnosis of familial Mediterranean fever","volume":"40","author":"Livneh\u00a0A","year":"1997","journal-title":"Arthritis\u00a0and Rheumatism"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub3-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/berh.2000.0089","article-title":"Diagnostic and treatment concerns in familial Mediterranean fever","volume":"14","author":"Livneh","year":"2010","journal-title":"Bailli\u00e8re's Best Practice & Research. Clinical Rheumatology"},{"issue":"10","key":"10.1002\/14651858.CD010893.pub3-BIB0084|cit84","first-page":"743-5, 782","article-title":"Amyloidosis\u00a0of\u00a0familial Mediterranean fever\u00a0(FMF)--insights to FMF phenotype II","volume":"145","author":"Livneh","year":"2006","journal-title":"Harefuah"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub3-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1182\/blood.V98.3.851","article-title":"The\u00a0familial\u00a0Mediterranean\u00a0fever\u00a0protein,\u00a0pyrin,\u00a0associates\u00a0with\u00a0microtubules\u00a0and\u00a0colocalizes\u00a0with\u00a0actin\u00a0filaments","volume":"98","author":"Mansfield","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1002\/14651858.CD010893.pub3-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/ard.59.11.910","article-title":"A survey of phenotype II in familial Mediterranean fever","volume":"59","author":"Meliko\u011flu","year":"2000","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub3-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MD.0b013e318277cf75","article-title":"Familial Mediterranean fever\u00a0in\u00a0Japan","volume":"91","author":"Migita","year":"2012","journal-title":"Medicine (Baltimore)"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement","volume":"62","author":"Moher","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"10","author":"Moher","year":"2012","journal-title":"International Journal of Surgery"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub3-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3899\/jrheum.100718","article-title":"Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine","volume":"38","author":"Ozen","year":"2011","journal-title":"Journal of Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub3-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"253","key":"10.1002\/14651858.CD010893.pub3-BIB0092|cit92","first-page":"1","article-title":"Familial Mediterranean fever: recent developments in pathogenesis and new recommendations for management","volume":"8","author":"Ozen","year":"2017","journal-title":"Frontiers in Immunology"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub3-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nature Immunology"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0094|cit94","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub3-BIB0095|cit95","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1084\/jem.173.3.699","article-title":"Thalidomide\u00a0selectively\u00a0inhibits\u00a0tumor\u00a0necrosis\u00a0factor\u00a0alpha\u00a0production\u00a0by\u00a0stimulated\u00a0human\u00a0monocytes","volume":"173","author":"Sampaio","year":"1991","journal-title":"Journal of Experimental Medicine"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0096|cit96","unstructured":"Sch\u00fcnemann HJ Oxman AD Vist GE Higgins JPT Deeks JJ Glasziou P Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub3-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/GIM.0b013e3182060456","article-title":"Familial\u00a0Mediterranean\u00a0fever--a\u00a0review","volume":"13","author":"Shohat","year":"2011","journal-title":"Genetics in Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.autrev.2012.07.019","article-title":"Familial Mediterranean fever:\u00a0new\u00a0phenotypes","volume":"12","author":"Soriano","year":"2012","journal-title":"Autoimmunity Reviews"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0099|cit99","unstructured":"Sterne JAC Egger M Moher D on behalf of the CBMG editor(s) Chapter 10: Addressing reporting biases. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"6","key":"10.1002\/14651858.CD010893.pub3-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.semarthrit.2008.08.006","article-title":"Colchicine\u00a0update:\u00a02008","volume":"38","author":"Terkeltaub","year":"2009","journal-title":"Seminars\u00a0in\u00a0Arthritis\u00a0and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD010893.pub3-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/ar4159","article-title":"Rilonacept\u00a0in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator","volume":"15","author":"Terkeltaub","year":"2013","journal-title":"Arthritis Research and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub3-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0092-8674(00)80539-5","article-title":"Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever","volume":"90","author":"The International FMF Consortium","year":"1997","journal-title":"Cell"},{"key":"10.1002\/14651858.CD010893.pub3-BIB0103|cit103","unstructured":"WHO 19th Expert Committee: Expert reviews www.who.int\/selection_medicines\/committees\/expert\/19\/reviews\/en\/index.html"},{"issue":"7517","key":"10.1002\/14651858.CD010893.pub3-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature13449","article-title":"Innate immune sensing of bacterial modifications of Rho GTPases by the Pyrin inflammasome","volume":"513","author":"Xu","year":"2014","journal-title":"Nature"},{"issue":"4","key":"10.1002\/14651858.CD010893.pub3-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/rheumatology\/ken509","article-title":"A new set of criteria for the diagnosis of familial Mediterranean fever in childhood","volume":"48","author":"Yal\u00e7inkaya","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1002\/14651858.CD010893.pub3-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1007\/s10067-012-2009-1","article-title":"Infliximab therapy for familial Mediterranean fever-related amyloidosis: case series with long term follow-up","volume":"31","author":"\u00d6z\u00e7akar","year":"2012","journal-title":"Clinical Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD010893.pub3-BIB0107|cit107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010893.pub2","article-title":"Interventions for reducing inflammation in familial Mediterranean fever","author":"Wu","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd010893.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:00:00Z","timestamp":1648512000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD010893.pub3\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T20:46:51Z","timestamp":1775249211000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD010893.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,10,19]]},"references-count":107,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2018,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010893.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,19]]}}}